Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FA4AV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,529
Award facts
- Contract value 100% obligated
- $21,529.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials, with a contract ceiling value of $21,529.15. This firm fixed price delivery order, with an ultimate completion date of September 23, 2025, represents a short-term pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate headquarters and a major hub for its federal pharmaceutical distribution operations.
This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare systems worldwide. AmerisourceBergen is a leading pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other Department of Defense healthcare programs. The company's extensive federal contract portfolio demonstrates its capability to supply a broad spectrum of medications, including specialty drugs, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains, with consistent delivery of both small-value and substantial orders through firm fixed price contracts.
Quick answers
Who was awarded contract SPE2DB25FA4AV?
SPE2DB25FA4AV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FA4AV worth?
The government has obligated $21,529 on SPE2DB25FA4AV.
Is contract SPE2DB25FA4AV an order under another contract?
Yes. SPE2DB25FA4AV is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA4AV competed?
The extent of competition for SPE2DB25FA4AV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award